New study shows what is required to reduce the prevalence of hyperglycemia throughout the subsequent day in type 2 diabetic patients….
Read More »A Nurse’s Perspective: Martha M. Funnell, MS, RN, CDE
In our practice we spend time in the community and encounter patients who are seeing primary care physicians and are on minimal therapy as well as patients from our clinic who are managed more aggressively….
Read More »Physicians’ Perspective: Gregory Peterson, MD, and Craig Spellman, MD
Gregory Peterson and Craig Spellman are two physicians who see a lot of diabetes patients in their practices, and are very familiar with the use of GLP-1 agonists. Both of them have written journal articles about the use of these newer medications….
Read More »An Educator’s Perspective: Michelle Laine, A.R.N.P., C.D.E.
Most of my colleagues wait till their patients are maxed out on oral medications — often this means that they are on 3 or 4 medications without achieving control, before starting them on either basal insulin or GLP-1 analogs….
Read More »A Pharmacist’s Perspective: Stuart T. Haines, PharmD, FCCP, FASHP, FAPhA
Patient Education and Monitoring Recommendations for the Use of GLP-1’s Unlike most diseases, diabetes requires extensive patient self-management….
Read More »Exercise and Sport in Diabetes, 2nd Ed., Part 6
2.7 Evaluation of the Intensity and Duration of the Effort The following is an excerpt that answers the questions regarding the evaluation of the intensity and duration of the effect of exercise. Intensity Effort intensity is well correlated with heart rate (HR) in the absence of heart rhythm abnormalities …
Read More »A Teaching Resource Guide, Part 1 of 2
Our Homerun Slides set this week, A Teaching Resource Guide, Part 1 of 2, is geared toward patient education and comes courtesy of Novo Nordisk. The program covers medications, hypoglycemia, nutrition, physical activity, monitoring and much more….
Read More »Korlym
Korlym Mifepristone (Korlym™, Corcept Therapeutics Inc.), was approved to manage hyperglycemia in patients with endogenous Cushing’s syndrome and type 2 diabetes mellitus or glucose intolerance who are not candidates for surgery or in whom surgical treatment has failed. This cortisol receptor blocker has potent antiprogestational properties and should never be …
Read More »Metformin May Treat a Leading Cause of Blindness
In laboratory rat and cell-culture experiments, the scientists found that metformin substantially reduced the effects of ….
Read More »Best Diabetes Combo to Treat Kids with Type 2 Diabetes
The best diabetes combination to treat kids with diabetes is….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.